Clinical Trial Update: A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating therapeutic drug monitoring-based dosing of atezolizumab across multiple cancers, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma | Phase 1 | Status: RECRUITING